Olema scores in Phase II breast cancer trial with Phase III dosing in weeks

Olema scores in Phase II breast cancer trial with Phase III dosing in weeks

Source: 
Clinical Trials Arena
snippet: 

Speaking to Clinical Trials Arena, Olema CEO Sean Bohen said that the first patient in Phase III will be dosed before the end of 2023.